Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07381192

An Artificial Intelligence System for Multimodal, Multi-class Diagnosing Solid Pancreatic Lesions Based on Endoscopic Ultrasound

Status
Recruiting
Phase
Study type
Observational
Enrollment
383 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to validate an artificial intelligence system named iEUS-SPL(intelligent endoscopic ultrasound system-solid pancreatic lesion) for detecting and multimodal, multi-class diagnosing solid pancreatic lesions during endoscopic ultrasound(EUS) examination.

Detailed description

This is an observational study with a prospective, cohort design. We have developed an artificial intelligence system named iEUS-SPL for multimodal, multi-class diagnosing solid pancreatic lesions using endoscopic ultrasound images, endoscopic ultrasound features, clinical data and imaging features from retrospectively collected patients who underwent EUS. The lesion detection rate and diagnostic performance of iEUS-SPL in identifying solid pancreatic lesions will be evaluated in real-time EUS scanning videos over prospective enrolled cases.

Conditions

Interventions

TypeNameDescription
DEVICEiEUS-SPL(intelligent endoscopic ultrasound system-pancreatic solid lesion)The iEUS-SPL will automaticly detect solid pancreatic lesions and integrate the patients' endoscopic ultrasound images, endoscopic ultrasound features, clinical data and imaging features to perform a five-category classification for the lesions, categorizing them as pancreatic cancer, pancreatic neuroendocrine tumor, solid pseudopapillary tumor, autoimmune pancreatitis and chronic pancreatitis.

Timeline

Start date
2025-09-01
Primary completion
2028-06-30
Completion
2028-06-30
First posted
2026-02-02
Last updated
2026-02-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07381192. Inclusion in this directory is not an endorsement.